List of works - Agnès Veyradier

A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture

scientific article published on March 2016

A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.

scientific article

ADAMTS13, von Willebrand factor specific cleaving protease

scientific article

Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease

scientific article

Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity

scientific article

Assays of ADAMTS-13 activity

scientific article published on January 2004

Assessment of endothelial damage and cardiac injury in a mouse model mimicking thrombotic thrombocytopenic purpura

scientific article

Atypical hemolytic and uremic syndrome associated with von Willebrand factor-cleaving protease (ADAMTS 13) deficiency in children ⬇️

scientific article published on July 1, 2013

Cancer awareness in atypical thrombotic microangiopathies

scientific article

Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency

scientific article

Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center

scientific article

Causes and risk factors of death in patients with thrombotic microangiopathies ⬇️

scientific article published on July 14, 2012

Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy

scientific article

Clopidogrel induced thrombotic thrombocytopenic purpura ⬇️

scientific article published on November 16, 2011

Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis

scientific article

Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples

scientific article

Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation And First ADAMTS 13 Mutation In A Tunisian Child ⬇️

scientific article published on June 3, 2013

Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

scientific article published on 01 March 2020

Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura ⬇️

scientific article published on January 21, 2012

Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

scientific article

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

scientific article

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

scientific article

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy

scientific article

Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF.

scientific article

Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement

scientific article

Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

scientific article published on 07 October 2019

Hereditary hemolytic uremic syndromes and thrombotic thrombocytopenic purpura

scientific article

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center

scientific article

High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome

scientific article

Human immunodeficiency virus-associated thrombotic microangiopathies

scientific article

Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity

scientific article

IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura

scientific article

Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease

scientific article

Macrovascular thrombosis in critically ill patients with thrombotic micro-angiopathies

scientific article

Pathophysiology of thrombotic microangiopathies: current understanding

scientific article

Pediatric thrombotic thrombocytopenic purpura

scientific article published on 22 August 2018

Plasma exchanges and replacement fluids for adult thrombotic microangiopathy. Synopsis of the Round table held on May 3, 2001

scientific article

Plasma therapy in von Willebrand factor protease deficiency

scientific article

Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome

scientific article

Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience

scientific article published on 23 April 2010

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

scientific article

Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity

scientific article

Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura

scientific article

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura

scientific article

Rituximab in autoimmune thrombotic thrombocytopenic purpura: A success story

scientific article

Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate

scientific article

Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement

scientific article

Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome

scientific article

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

scientific article

Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

scientific article

Telemedicine in thrombotic microangiopathies: A way forward in rare diseases requiring emergency care

scientific article

Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

scientific article

The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation

scientific article

The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy

scientific article

Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors

scientific article

Thrombotic microangiopathies: towards a pathophysiology-based classification

scientific article

Thrombotic thrombocytopenic purpura and its diagnosis

scientific article

Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children

scientific article

Thrombotic thrombocytopenic purpura in children.

scientific article

Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre

scientific article

Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children

scientific article

Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome

scientific article

Thrombotic thrombocytopenic purpura: from diagnosis to therapy

scientific article

Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange

scientific article

Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

scientific article

Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19

scientific article published on 15 May 2020

Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura ⬇️

scientific article published on April 30, 2012

Unresponsive thrombotic thrombocytopenic purpura in critically ill adults

scientific article

[Thrombotic thrombocytopenic purpura in a newborn].

scientific article

List of works by Agnès Veyradier

A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture

A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.

ADAMTS13, von Willebrand factor specific cleaving protease

Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease

Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity

Assays of ADAMTS-13 activity

Assessment of endothelial damage and cardiac injury in a mouse model mimicking thrombotic thrombocytopenic purpura

Atypical hemolytic and uremic syndrome associated with von Willebrand factor-cleaving protease (ADAMTS 13) deficiency in children ⬇️

Cancer awareness in atypical thrombotic microangiopathies

Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency

Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center

Causes and risk factors of death in patients with thrombotic microangiopathies ⬇️

Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy

Clopidogrel induced thrombotic thrombocytopenic purpura ⬇️

Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis

Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples

Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation And First ADAMTS 13 Mutation In A Tunisian Child ⬇️

Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura ⬇️

Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy

Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF.

Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement

Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

Hereditary hemolytic uremic syndromes and thrombotic thrombocytopenic purpura

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center

High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome

Human immunodeficiency virus-associated thrombotic microangiopathies

Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity

IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura

Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease

Macrovascular thrombosis in critically ill patients with thrombotic micro-angiopathies

Pathophysiology of thrombotic microangiopathies: current understanding

Pediatric thrombotic thrombocytopenic purpura

Plasma exchanges and replacement fluids for adult thrombotic microangiopathy. Synopsis of the Round table held on May 3, 2001

Plasma therapy in von Willebrand factor protease deficiency

Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome

Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity

Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura

Rituximab in autoimmune thrombotic thrombocytopenic purpura: A success story

Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate

Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement

Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

Telemedicine in thrombotic microangiopathies: A way forward in rare diseases requiring emergency care

Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation

The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy

Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors

Thrombotic microangiopathies: towards a pathophysiology-based classification

Thrombotic thrombocytopenic purpura and its diagnosis

Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children

Thrombotic thrombocytopenic purpura in children.

Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre

Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children

Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome

Thrombotic thrombocytopenic purpura: from diagnosis to therapy

Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange

Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19

Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura ⬇️

Unresponsive thrombotic thrombocytopenic purpura in critically ill adults

[Thrombotic thrombocytopenic purpura in a newborn].